Clinical trial NCT04082871: Medication Review in Women With Depression and Anxiety
Official title: Assessing the Impact of Medication Management Review Service for Females Diagnosed With Depression and Anxiety
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Depression, Anxiety
Adherence, Patient
Keywords: Medication management review service
Pharmaceutical care
Clinical pharmacist
Lead sponsor: Applied Science Private University
Sponsor class: OTHER
First posted: 2019-09-09
Enrollment: 73
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Following recruitment, participants were randomized into two groups (1:1 randomization), active and control, using the computer-generated randomization program (www.randomization.com). The researcher generated the allocation sequence, and assigned the participants to their group. Participant who came into the clinic during the clinic's working hours (Sunday to Thursday, from 9 am to 1 pm) were approached consecutively and allocated to the active or control group. Participants were not aware of which study group they were assigned to; only the researcher was aware of each patient's group assignment.

Participants in the active and control groups completed a baseline and follow-up (3 months from baseline) visits at the same outpatient psychiatric clinic with the researcher conducting the interview using the study tool to complete the MMR process.
Primary purpose: TREATMENT

Brief summary: This study sought to assess the impact of the MMR service on identifying and resolving TRPs, improving adherence, depression and anxiety scores in females diagnosed with depression and anxiety in Jordan

Detailed description: Participants were recruited into this single-blind parallel randomized controlled trial and randomized into active and control groups. A clinical pharmacist identified TRPs for all participants. Adherence, depression and anxiety scores were assessed. Active group patients received the MMR service: pharmacist-delivered counseling and a letter with recommended changes in the patient's treatment plan was sent to the patient's psychiatrist to be applied. Control group participants did not receive the intervention. Follow-up assessments were completed for all patients at 3 months from baseline. Main outcome measures were TRPs, adherence, depression and anxiety scores.

Eligibility criteria: Inclusion Criteria:

* Jordanian females or residents in Jordan for the last 12 months and planning to stay in Jordan for 6 months (the study follow-up period),
* above the age of 18 years
* diagnosed with depression and/or anxiety for at least 4 weeks duration
* taking medications for depression and/or anxiety

Exclusion Criteria:

* presence of a cognitive problem or sensory impairment which may prevent communication with the patient (reported by the patient's psychiatrist)
* being not able to speak or write Arabic (reported by the patient)

Primary outcomes:
measure: Evaluate the effect of the medication management review service delivered to females living in Jordan and diagnosed with depression and anxiety
timeFrame: 6 months
Secondary outcomes:
measure: Patient's satisfaction with the medication management review service
timeFrame: 6 months
Other outcomes:
Locations:
Study officials:
References: